Lumexa Imaging indicated to open at $19, IPO priced at $18.50

Lumexa Imaging (LMRI) priced 25M shares at $18.50. The deal priced at the midpoint of the $17.00-$20.00 target range. Barclays, JPMorgan and Jefferies are acting as joint book running managers for the offering. Lumexa Imaging is a provider of diagnostic imaging services whose affiliates operated the second largest outpatient imaging center footprint in the United States as of September 30, spanning 184 centers across 13 states.